Ethic Inc’s Dynavax Technologies DVAX Stock Holding History

Ethic Inc’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,967	Closed	-$152K	–	1241
2025 Q1	$152K	Buy	+11,967	New	+$158K	﹤0.01%	1090

Other funds holding DVAX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Ethic Inc's DVAX Position: Q2 2025 in Review

Ethic Inc sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 11,967 shares — an estimated $152K sold.

Ethic Inc first reported a position in DVAX in Q1 2025 and held it in 1 quarter. The position peaked at $152K in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

Ethic Inc reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
Ethic Inc sold 11,967 Dynavax Technologies shares in Q2 2025, an estimated $152K.
Ethic Inc first reported a position in Dynavax Technologies in Q1 2025 and held it in 1 quarter.
Ethic Inc's Dynavax Technologies position peaked at $152K in Q1 2025.
268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Ethic Inc's 13F filing for Q2 2025, filed 30 Jul 2025.